BMS1P22

Across TCGA pan-cancer cohorts, BMS1P22 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated BMS1P22 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher BMS1P22 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated BMS1P22 expression acts as an unfavorable survival marker, although some lineages such as UCS and READ show a favorable association.

UCS, KIRC, and UCEC are the cancer types where BMS1P22 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Median	II,III,IV	0.630	0.245	<.001	90	view →
KIRC	DFS	Tertile	All	0.536	0.711	<.001	83	view →
UCEC	OS	Tertile	All	0.540	0.775	<.001	78	view →
LIHC	OS	Tertile	All	0.563	0.747	<.001	63	view →
KIRP	DFS	Quartile	All	0.840	0.940	.002	35	view →
LUAD	OS	Median	All	0.770	0.848	.004	34	view →
ACC	DFS	Median	All	0.304	0.612	.003	32	view →
READ	DFS	Median	All	0.883	0.574	.009	31	view →
DLBC	DFS	Median	IV	0.128	1.000	.017	22	view →
SARC	OS	Median	All	0.667	0.817	<.001	21	view →
CESC	OS	Median	II,III,IV	0.907	0.770	.018	12	view →
UVM	OS	Tertile	All	0.670	0.955	.022	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

BMS1P22–UCS (DFS)

Open the UCS breakdown →